...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: TD Waterhouse-TFSA
1
Dec 13, 2017 06:50PM
1
Dec 14, 2017 05:15AM
5
Dec 15, 2017 09:00AM
2
Dec 15, 2017 09:25AM
2
Dec 15, 2017 10:39AM

Just for myself, I'd want to see the eligibility of ZEN shares written in the TFSA rules.  And I sure don't see it.  Significant penalties for getting it wrong....

 

 


Dec 18, 2017 01:38PM
Share
New Message
Please login to post a reply